Equities researchers at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
NYSE CPHI opened at $0.24 on Friday. China Pharma has a one year low of $0.13 and a one year high of $0.44. The company has a 50-day simple moving average of $0.22 and a 200-day simple moving average of $0.22. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22.
About China Pharma
Read More
- Five stocks we like better than China Pharma
- How to Invest in the Best Canadian Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Insider Trading – What You Need to Know
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How Can Investors Benefit From After-Hours Trading
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
